FDA Director Alonza Cruse to Deliver Keynote Address at the 2020 ISPE Aseptic Conference


Alonza Cruse, Director, Office of Pharmaceutical Quality Operations, FDA/ORA

The International Society for Pharmaceutical Engineering (ISPE) announced Alonza Cruse, Director, Office of Pharmaceutical Quality Operations, FDA/ORA, as a newly confirmed keynote for the 2020 ISPE Aseptic Conference, taking place 2–3 March 2020 in North Bethesda, Maryland.

His office is responsible for all pharmaceutical quality inspections and investigations, working in conjunction with the FDA’s Center for Drug Evaluation & Research and the Center for Veterinary Medicine. Additionally, he is leading ORA’s pharmaceutical collaboration efforts under the Program Alignment initiative.

Alonza Cruse will provide current regulatory perspectives on aseptic processing during his keynote presentation. He is also a featured panelist in the Interactive Regulatory Panel session, where he will answer the most pressing quality and regulatory questions directly with six FDA colleagues, including:


  • Brooke Higgins, Senior Policy Advisor, Office of Manufacturing Quality, Division of Drug Quality, FDA/CDER/OC/OMQ
  • Christine Harman, PhD, Chemist, Review Branch 1, FDA
  • Jie He, Facility Inspection and CMC Review Branch 2, US FDA
  • Richard Friedman, Deputy Director, Science and Regulatory Policy, FDA/CDER
  • Robert Sausville, Director, Div. Case Management, FDA/CBER/OMPT/OCBQ
  • Zhihao Qiu, PhD, Director (Acting), Office of Pharmaceutical Manufacturing Assessment, FDA/CDER/OPQ/OPF

Now in its 29th year, the 2020 ISPE Aseptic Conference has established itself as the pharmaceutical industry’s leading source on advancing aseptic and barrier operations and providing invaluable opportunities for peer-to-peer learning through interactions with industry and regulatory leaders.

To explore the agenda and to register, please visit ISPE.org/Aseptic20.

About ISPE

The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit ISPE.org for more information.

For more information, contact:

Amy Henry

Marketing Communications Manager

International Society for Pharmaceutical Engineering (ISPE)

Tel: +1-813-960-2105

Email: ahenry@ispe.org

ISPE.org

Share article on social media or email:

Leave a Reply